Opipramol Neuraxpharm (Opipramol Hydrochloride)

Opipramol Hydrochloride, the active ingredient in Opipramol Neuraxpharm, is a tricyclic antidepressant presented as a tablet for oral use. It is primarily prescribed for anxiety disorders and depressive symptoms in adult patients. GNH USA supplies Opipramol Neuraxpharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Opipramol Neuraxpharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Opipramol Neuraxpharm is used in the management of anxiety‑related conditions and depressive disorders, acting on central nervous system pathways that regulate mood and stress response.

- Generalized Anxiety Disorder: reduces excessive worry and tension. - Somatic Symptom Disorder: alleviates physical symptoms linked to anxiety. - Major Depressive Disorder: improves mood and functional capacity. - Panic Disorder: decreases frequency and intensity of panic attacks. - Adjustment Disorder with Anxiety: helps patients adapt to stressors with fewer anxiety symptoms.

Opipramol Neuraxpharm may cause a range of adverse reactions, most of which are dose‑dependent and reversible upon discontinuation.

Common Side Effects: - Drowsiness: feeling ​  ... - Dry mouth: reduced salivation. - Constipation: slowed gastrointestinal motility. - Weight gain: increased appetite or fluid retention. - Dizziness: light‑headed ​  .... - Blurred  ...  ...  ...  ...  ... .

Serious or Rare Side Effects: - Cardiac arrhythmias: irregular heart rhythm. - Severe hypotension: marked low  ...  . - Hepatotoxic  ...  . - Stevens‑Stevens   ... . -      ...      ...  . -       ...     …  .

Opipramol Neuraxpharm      …  …  …  …  …  … …  …  …  …